Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy-Reference-Cited by-同舟云学术

Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy

Published:2017-06 Issue: Volume:377 Page:144-148
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Gazzola Sébastien,Delmont Emilien,Franques Jérôme,Boucraut José,Salort-Campana Emmanuelle,Verschueren Annie,Sagui Emmanuel,Hubert Anne-Michèle,Pouget Jean,Attarian Shahram

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference26 articles.

1. Prevalence of monoclonal gammopathy of undetermined significance;Kyle;N. Engl. J. Med.,2006

2. Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies;Vrethem;J. Neurol. Sci.,1993

3. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society;Joint Task Force of the EFNS and the PNS;J. Peripher. Nerv. Syst.,2010

4. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases;Chassande;Muscle Nerve,1998

5. Neuropathy associated with “benign” anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases;Ellie;J. Neurol.,1996

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges;Journal of the Peripheral Nervous System;2024-06

2. Paraproteinemic neuropathies;Muscle & Nerve;2024-05-30

3. Paraproteinemia‐associated neuropathy with or without anti‐myelin‐associated glycoprotein antibody;Clinical and Experimental Neuroimmunology;2024-02-26

4. Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials;Arquivos de Neuro-Psiquiatria;2024-02-07

5. Therapeutic Outcomes and Electrophysiological Biomarkers in Anti-Myelin-Associated Glycoprotein Neuropathy: A Multicenter Cohort Study in South Korea;Journal of Clinical Neurology;2024